After seeing shares of its spinoff
Mead Johnson Nutrition (NYSE: MJN) nearly
double since its
IPO in February,
Bristol-Myers Squibb (NYSE: BMY) has decided
now's the time to sell the 83% of the baby formula producer
that it still owns.
Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision.
Recent comments
16 hours 35 min ago
18 hours 19 min ago
19 hours 55 min ago
1 day 2 hours ago
1 day 16 hours ago
2 days 6 hours ago
2 days 20 hours ago
3 days 12 hours ago
3 days 14 hours ago
3 days 15 hours ago